Subscribe
T. Schneider / Shutterstock.com
18 March 2025NewsAmericasMuireann Bolger

Tempus sues competitor over AI cancer diagnostic tech

Complaint centres on AI-powered tools for cancer diagnostics | Tempus says its rival has a history of deliberately copying competitors’ technologies.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Cancer specialist to pay $83.4m over DNA sequencing infringement
16 November 2023   TwinStrand Biosciences and the University of Washington win patent infringement case related to DNA mutation technology.
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024   Biotech takes legal action against Tempus AI, alleging patent infringement in Tempus's liquid biopsy products | Complaint accuses Tempus of unauthorised use of Guardant's tech crucial for cancer diagnostics.


Editor's picks

Americas
Trouble at the USPTO—Part II: Bracing for impact
13 March 2025

Editor's picks

Americas
Trouble at the USPTO—Part II: Bracing for impact
13 March 2025
Americas
Trouble at the USPTO—Part I: Why government cutbacks are making everyone nervous
6 March 2025
Americas
‘Lift as you climb’: Abbott, BMS, Hitachi, LEGO Group counsels explore ‘empowerment’
6 March 2025
Careers
Jones Day adds experienced patent litigators from Weil
4 March 2025
Americas
LSPN finalists revealed for first-ever US awards
3 March 2025
Europe
‘It’s business as usual’: ERS Genomics enjoys new EPO patent after CRISPR gambit pays off
27 February 2025

More on this story

Americas
Cancer specialist to pay $83.4m over DNA sequencing infringement
16 November 2023   TwinStrand Biosciences and the University of Washington win patent infringement case related to DNA mutation technology.
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024   Biotech takes legal action against Tempus AI, alleging patent infringement in Tempus's liquid biopsy products | Complaint accuses Tempus of unauthorised use of Guardant's tech crucial for cancer diagnostics.

More on this story

Americas
Cancer specialist to pay $83.4m over DNA sequencing infringement
16 November 2023   TwinStrand Biosciences and the University of Washington win patent infringement case related to DNA mutation technology.
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024   Biotech takes legal action against Tempus AI, alleging patent infringement in Tempus's liquid biopsy products | Complaint accuses Tempus of unauthorised use of Guardant's tech crucial for cancer diagnostics.

More features

Verily, IBM, litigation funder on the art of leveraging patents
Trouble at the USPTO—Part II: Bracing for impact
‘We need the top 50 law firms to stand up’: Will Perkins Coie ignite Trump resistance?
Trump chooses crypto-focused litigation funding expert to lead USPTO
Novo Nordisk strikes again over Wegovy generic
Fed Circ removes Apple import watch ban threat
Blank Rome bolsters patent litigation with Houston partner hire
Trouble at the USPTO—Part I: Why government cutbacks are making everyone nervous